Related Funds
Fund Name | Location |
CDAM | England, London, United Kingdom |
Credence Partners | Central, Central Region, Singapore |
Crimson Group | Japan, Tokyo |
EUREKAP! | - |
HyogoBenderEngineering | Himeji, Hyogo Prefecture, Japan |
JGC Holdings Corporation | Japan, Kanagawa Prefecture, Yokohama |
Leonardo DiCaprio Foundation | California, Los Angeles, United States |
MGV Capital Group | San Antonio, Texas, United States |
Mosaix Ventures | Chicago, Illinois, United States |
Net Capital Ventures | Israel, Ramat Gan, Tel Aviv |
S.Capital | - |
SBI Investment Korea | Seoul, Seoul-t'ukpyolsi, South Korea |
Sherpa InnoVentures | Israel, Tel Aviv, Tel Aviv District |
Tech Capital Partners | Canada, Ontario, Waterloo |
The Boston Foundation | Boston, Massachusetts, United States |
Tomahawk.VC | Switzerland, Zürich, Zurich |
Union Kitchen | District of Columbia, United States, Washington |
WhiteRock Capital Partners | Belfast, Northern Ireland, United Kingdom |
Xinhuo Capital | China, Futian, Guangdong |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Milsora Pharmaceuticals & Bio-tech Cosmetics | 16 Mar 2021 | Istanbul, Istanbul, Turkey | |||
Jaaims | $474K | 30 Sep 2019 | Sydney, New South Wales, Australia | ||
$265K | 30 Mar 2019 | Entre Ríos Province, Argentina |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Milsora Pharmaceuticals & Bio-tech Cosmetics | 16 Mar 2021 | Istanbul, Istanbul, Turkey | |||
Jaaims | $474K | 30 Sep 2019 | Sydney, New South Wales, Australia | ||
$265K | 30 Mar 2019 | Entre Ríos Province, Argentina |